InterShunt has initiated the EASE HF2 early feasibility study of the InterShunt percutaneous atrial shunt catheter (PAS-C) ...

Philips has announced the expansion of its collaboration with Medtronic, focusing on advancing patient monitoring ...

It is no secret that the UK’s National Health Service (NHS), like many other healthcare systems, is under pressure on ...

A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.

Enterra Medical has commenced the randomised, multi-centre NAVIGATE study, designed to assess Gastric Electrical Stimulation ...

Medical Research Council (MRC) has launched a new £50m ($68.6m) centre spread across collaborator sites in the UK to develop ...

The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.

A professor from the University of Sheffield has received over £0.39m ($0.45m) in funding from Breast Cancer Now to develop a ...

Glaukos has secured EU Medical Device Regulation (EU-MDR) certification for its iStent infinite, along with other MIGS ...

Vivasure Medical has submitted an application seeking premarket approval from the FDA for its PerQseal Elite vascular closure ...

Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...

ITM and Swiss-based Debiopharm have announced the imaging of the first subject in a new study arm (Part D) of the Phase I/II ...